Finance

Beta
Lists
4967:TYO
Kobayashi Pharmaceutical Co Ltd
Â¥5,680.00
+0.32%
(+18.00) 1D
Jun 3, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4967...
Open
Â¥5,699
High
Â¥5,701
Low
Â¥5,622
Mkt. cap
443.32B
Avg. vol.
198.93K
Volume
222.90K
Dividend
1.83%
Quarterly dividend
Â¥26
Ex-dividend date
Jun 29, 2026
P/E ratio
137.63
52-wk high
Â¥6,140
52-wk low
Â¥5,030
EPS
Â¥41
Shares outstanding
79.07M
No. of employees
4K
Open
Â¥5,699
High
Â¥5,701
Low
Â¥5,622
Mkt. cap
443.32B
Avg. vol.
198.93K
Volume
222.90K
Dividend
1.83%
Quarterly dividend
Â¥26
Ex-dividend date
Jun 29, 2026
P/E ratio
137.63
52-wk high
Â¥6,140
52-wk low
Â¥5,030
EPS
Â¥41
Shares outstanding
79.07M
No. of employees
4K
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to 4967 in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for 4967 in the last 3 months.
Highest
Current ¥5,680.00
Â¥5,200.00 (-8.45%)
Average
Â¥5,199.94 (-8.45%)
Lowest
Â¥5,200.00 (-8.45%)
News stories
From sources across the web
About Kobayashi Pharmaceutical Co Ltd
CEOKazumasa Kobayashi
Employees3.73K
FoundedAug 22, 1919
Headquarters-
SectorPersonal care products
Last report
May 8, 2026
Fiscal period
Q1 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
33.66B / 33.65B
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
36.41B
43.02B
53.70B
33.66B
Cost of goods sold
16.95B
20.30B
27.85B
16.23B
Cost of revenue
16.95B
20.30B
27.85B
16.23B
Research and development expenses
-
-
9.12B
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.35B
17.87B
6.76B
16.09B
Operating expense
15.29B
17.87B
22.50B
16.13B
Total operating expenses
32.24B
38.17B
50.36B
32.35B
Operating income
4.17B
4.85B
3.35B
1.31B
Other non operating income
316.00M
593.00M
-150.00M
227.00M
EBT including unusual items
2.51B
5.02B
-5.52B
1.74B
EBT excluding unusual items
4.84B
5.68B
4.07B
1.67B
Income tax expense
965.00M
1.37B
-2.37B
699.00M
Effective tax rate
38.51%
27.33%
42.97%
40.26%
Other operating expenses
-
-
1.26B
-
Net income
1.54B
3.64B
-3.15B
1.04B
Net profit margin
4.24%
8.47%
-5.87%
3.08%
Earnings per share
-
-
-
-
Interest and investment income
400.00M
94.00M
448.00M
137.00M
Interest expense
-8.00M
-3.00M
-13.00M
-4.00M
Net interest expenses
392.00M
91.00M
435.00M
133.00M
Depreciation and amortization charges
-
-
3.89B
-
EBITDA
6.32B
6.85B
5.53B
3.50B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more